compounded semaglutide crackdown news today The market for GLP-1 drugs remained robust despite the end of (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with Hims to stop offering GLP-1

FDA: Approval of Zepbound (tirzepatide) for weight management

In addition, weight loss medications are generally not prescribed for patients with eating disorders, and, therefore, patients should be screened for these conditions

According to the complaint, the company markets these medications directly to consumers through its websites and coordinates fulfillment through partner pharmacies

Additionally, steer clear of skipping meals or making significant changes to your diet without proper guidance

Additionally, decreased intestinal cholesterol absorption in patients with insulin resistance and obesity may limit increases in LDL-C levels [15]